leadf
logo-loader
viewZaim Credit Systems

ZAIM Credit Systems gets price upgrade after solid quarter

Broker Optiva's target is now 8.61p compared to 8p previously

Zaim Credit Systems -

ZAIM Credit Systems PLC (LON:ZAIM) has received a price target upgrade to 8.61p from broker Optiva, which cited improving cashflow as well as peer comparisons for the change.

The new target, which implies a valuation of £37.6mln, compares to its previous target of 8p and reflects progress both since its IPO in both derisking and diversifying its business model, said the broker.

Cashflow is more important in this methodology, Optiva said, as having now shown proof of concept there is evidence to suggest ZAIM could achieve consistent profitability in the near term.

 AIM-listed ZAIM is a microfinance lender focused on Russia that provides small short-term loans.

Microfinance is well-established and tightly regulated in Russia, adds Optiva, where one in 10 adults did not have a bank account in 2018,

Due to COVID-19 restrictions, ZAIM has recently switched its focus to online and mobile from shops and in the third quarter of 2020 50% of loans were generated in this way.

The company also became operating cashflow positive during the quarter, noted Optiva, despite significant sector uncertainty due to COVID.

Shares rose 11% to 2.9p.

Quick facts: Zaim Credit Systems

Price: 4.4 GBX

LSE:ZAIM
Market: LSE
Market Cap: £19.23 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zaim Credit Systems named herein, including the promotion by the Company of Zaim Credit Systems in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: No deal Brexit fears, Glaxo’s vaccine disappointment and...

FTSE 100 retreated as investors mulled Boris Johnson’s sobering no-deal Brexit warning despite Airbnb’s eye-raising debut. Glaxo’s vaccine disappointment also unsettled London’s blue chip index, which dipped 59 to 6,540 early. Shares of Airbnb rocketed higher in the first day’s trading...

on 11/12/20

2 min read